跳至主要内容
临床试验/NCT04213547
NCT04213547招募中不适用

Sleep Duration and Glycemic Control in Adolescents With Type 2 Diabetes Mellitus

Children's Hospital of Philadelphia1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2020年9月16日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
90
试验地点
1
主要终点
Qualitative data from focus group

研究概览

简要总结

The primary objective is to determine the cross-sectional relationship between sleep duration (as measured by 14 days of actigraphy) and glycemic control in an adolescent Type 2 Diabetes (T2DM) cohort (age 12-20y, n=67). A secondary objective is to determine if a loss-framed incentive for achieving sleep goals can increase sleep duration in 15 adolescent patients diagnosed with T2DM with insufficient sleep. Another secondary objective is to test if increasing sleep duration leads to improved glycemic control in 15 adolescents with T2DM identified in Aim 1 as having <8 hr sleep/evening. A focus group will be conducted prior to this intervention with patients ineligible for the intervention in order to determine appropriate text messaging.

详细描述

Aim 1 will be a cross-sectional study design utilizing actigraphy watch devices to estimate sleep duration. Participants will be recruited either before or after a routine outpatient clinic visit and asked to complete intake questionnaires. They will then be provided an actigraphy watch device which will be worn for 14 days to estimate sleep duration, and Libre continuous glucose monitor (CGM) to estimate glycemic control. After their visit, clinical data will be extracted from the electronic medical record.

Aim 2 will be an interventional study design utilizing Fitbit to perform a loss-framed incentive intervention designed to motivate participants to increase their sleep duration. Glycemic control will be measured via laboratory testing of hemoglobin A1c and Libre continuous glucose monitoring (CGM) for 2 weeks pre- and post-intervention.

A focus group will be conducted prior to this intervention with patients ineligible for the intervention in order to determine appropriate text messaging.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
12 Years 至 20 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Aim 1 for child:
  • Subjects age 12-20
  • Diagnosed with T2DM by standard laboratory criteria without pancreatic autoimmunity
  • Low probability of obstructive sleep apnea (OSA) assessed via validated sleep survey
  • Subjects will be included if they are taking T2DM treatments (i.e., diet modification, Metformin and/or insulin)
  • Parental/guardian permission and child assent
  • Aim 1 for parent:
  • 1. Parent or legal guardian of child that meets inclusion criteria for Aim
  • Aim 2 for child:
  • Completed Aim 1 evaluation
  • Average sleep duration < 8 hours per night as determined by actigraphy in Aim 1
  • HbA1c ≤ 10% as HbA1c >10 correlates to poor adherence
  • Adherence > 80%
  • Focus group for child:
  • Subjects aged 12-20
  • Diagnosed with type 2 diabetes without pancreatic autoimmunity

排除标准

  • Aim 1 for child:
  • Non-English speaking subject (as questionnaires used are validated in English)
  • Institutionalized patients as sleep duration will not be of their own accord, and therefore is not generalizable to the rest of the adolescent T2DM population.
  • Patients with other forms of Diabetes Mellitus (e.g. Type 1 Diabetes)
  • Behavioral disorders that may affect data collection (e.g. autism spectrum disorder) will be determined on a case-by-case basis. These include patients that are unable to answer questionnaires on their own, participate in a sleep diary, wear devices and/or understand incentives.
  • Oral or IV steroid treatment within the past month
  • Females with known pregnancies as these patients will not be generalizable to the rest of the adolescent T2DM population and pregnancy may alter sleep duration.
  • Subjects with known hyperthyroidism, pain syndrome, or serious medical condition that can affect sleep.
  • Subjects with hemoglobinopathies that affect hemoglobin A1c measurement.
  • Unable to obtain point-of-care hemoglobin A1c in clinic on date of recruitment
  • Known diagnosis of obstructive sleep apnea or other sleep disorder
  • Aim 1 for Parent:
  • Non-English speaking subject (as questionnaires used are validated in English)
  • Parent/guardians with cognitive disorders that may affect data collection (determined on a case-by-case basis)
  • Aim 2 for child:
  • 1. Do not own a smart phone or tablet
  • Focus group for child:
  • Non-English speaking subject (as focus group will be conducted in English)
  • Lack of access to a computer, tablet or smartphone that can accommodate participation in video conferencing

研究组 & 干预措施

Intervention

Experimental

This will be a single-arm study utilizing a loss-framed incentive intervention to induce increased sleep duration.

干预措施: Loss frame sleep extension intervention (Behavioral)

结局指标

主要结局

Qualitative data from focus group

时间窗: baseline at focus group

Qualitative output from focus group discussion on text messages

Hemoglobin A1c (for Aim 1)

时间窗: baseline

Aim 1 is assessing cross-sectional relationship of A1c to sleep duration

BMI (for Aim 1)

时间窗: baseline

Aim 1 is assessing cross-sectional relationship of BMI to sleep duration

Sleep duration (for Aim 2)

时间窗: 13 weeks

Will assess for sleep extension throughout intervention

次要结局

  • BMI(13 weeks)
  • Glycemic control(13 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验